Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials
暂无分享,去创建一个
J. Fawcett | J. Steeves | B. Dobkin | V. Dietz | M. Tuszynski | P. Ellaway | R. Grossman | A. Curt | M. Fehlings | J. Guest | D. Short | J. Ditunno | A. Privat | A. Blight | M. Nakamura | M. Fehlings | W. Coleman | N. Kleitman | J. Steeves | L. Havton | D. Lammertse | D. Lammertse | P. Bartlett | A. Blight | M. Gaviria | Masaya Nakamura | M. Nakamura | Leif A. Havton | John F. Ditunno | James W. Fawcett | Armin Curt | John D. Steeves | Daniel P. Lammertse | Andrew R. Blight | Bruce H. Dobkin | Michael G. Fehlings | Robert G. Grossman | Perry F. Bartlett
[1] R. Waters,et al. Motor and sensory recovery following complete tetraplegia. , 1993, Archives of physical medicine and rehabilitation.
[2] W. Donovan,et al. Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems. , 1999, Archives of physical medicine and rehabilitation.
[3] R. Waters,et al. Motor and sensory recovery following incomplete paraplegia. , 1994, Archives of physical medicine and rehabilitation.
[4] W. Collins,et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. , 1991, The New England journal of medicine.
[5] F. Geisler,et al. Prognostic value of pinprick preservation in motor complete, sensory incomplete spinal cord injury. , 2005, Archives of physical medicine and rehabilitation.
[6] J. Ditunno,et al. Establishing Prognosis and Maximizing Functional Outcomes After Spinal Cord Injury: A Review of Current and Future Directions in Rehabilitation Management , 2001, Spine.
[7] F. Geisler,et al. Injury severity as primary predictor of outcome in acute spinal cord injury: retrospective results from a large multicenter clinical trial. , 2003, The spine journal : official journal of the North American Spine Society.
[8] W. Collins,et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. , 1992, Journal of neurosurgery.
[9] Steven Kirshblum,et al. Late neurologic recovery after traumatic spinal cord injury. , 2004, Archives of physical medicine and rehabilitation.
[10] A. Jackson,et al. Recovery of upper-extremity strength in complete and incomplete tetraplegia: a multicenter study. , 2000, Archives of physical medicine and rehabilitation.
[11] R. Waters,et al. 1997 Munro Lecture Presented at the 43rd Annual Conference of the American Paraplegia Society Functional and Neurologic Recovery Following Acute SCI , 1998 .
[12] A. Privat,et al. Early care and treatment with a neuroprotective drug, gacyclidine, in patients with acute spinal cord injury , 2003 .
[13] H. Winn,et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. , 1997, JAMA.
[14] S L Stover,et al. Motor recovery of the upper extremities in traumatic quadriplegia: a multicenter study. , 1992, Archives of physical medicine and rehabilitation.
[15] C. Fisher,et al. Motor Recovery, Functional Status, and Health-Related Quality of Life in Patients With Complete Spinal Cord Injuries , 2005, Spine.
[16] R. Waters,et al. Donal Munro Lecture: Functional and neurologic recovery following acute SCI. , 1998, The journal of spinal cord medicine.
[17] H. Winn,et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. , 1998, Journal of neurosurgery.
[18] J. Fawcett,et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures , 2007, Spinal Cord.
[19] H. Winn,et al. Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial , 1997 .
[20] A. Tessler,et al. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. , 2003, Journal of neurotrauma.
[21] F. Geisler,et al. Measurements and Recovery Patterns in a Multicenter Study of Acute Spinal Cord Injury , 2001, Spine.
[22] R. Marino,et al. The 72-hour examination as a predictor of recovery in motor complete quadriplegia. , 1991, Archives of physical medicine and rehabilitation.
[23] F. Geisler,et al. The Sygen® Multicenter Acute Spinal Cord Injury Study , 2001, Spine.
[24] J. Fawcett,et al. Report of International Clinical Trials Workshop on Spinal Cord Injury February 20–21, 2004, Vancouver, Canada , 2004, Spinal Cord.